Levetiracetam Biogaran

Levetiracetam, the active ingredient in Levetiracetam Biogaran, is an antiepileptic presented as an oral tablet for oral use. It is used to control partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy and to reduce seizure frequency and severity.

GNH USA supplies Levetiracetam Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Our network includes regulatory support and after‑sales service to ensure continuous patient access.

Levetiracetam is an antiepileptic that modulates neuronal excitability to treat several seizure types.

Partial‑onset seizures: reduces frequency of focal seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: diminishes rapid muscle jerks associated with epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Fatigue: unusual tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Nausea: feeling of stomach upset or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Psychiatric changes: depression, anxiety, or suicidal thoughts. - Blood disorders: thrombocytopenia or leukopenia.

Before prescribing Levetiracetam, clinicians should consider several safety considerations.

Renal impairment: adjust dose based on creatinine clearance. Hepatic dysfunction: monitor liver enzymes regularly. Psychiatric history: observe for mood changes or suicidal ideation. Concomitant CNS depressants: assess additive sedation risk. Pregnancy: use only if potential benefit justifies potential risk. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy. - Phenobarbital: enzyme induction can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: combined CNS depression may increase dizziness and sedation. - Other antiepileptics (e.g., valproate): monitor seizure control and plasma levels. - Antidepressants (e.g., SSRIs): watch for increased behavioral changes.